Development of arsenic trioxide sustained-release pellets for reducing toxicity and improving compliance.

Liu, Xiao; Zhou, Ping; Yang, Yueying; Liu, Jingxuan; Widjaya, Andy Samuel; Jiang, Yanyan

Liu, Xiao; Zhou, Ping; Yang, Yueying; Liu, Jingxuan; Widjaya, Andy Samuel; Jiang, Yanyan.

Afiliação

Liu X; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai, China.
Zhou P; Haerbin Yida Pharmaceutical Co., Ltd., Haerbin, China.
Yang Y; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai, China.
Liu J; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai, China.
Widjaya AS; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai, China.
Jiang Y; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai, China.

Drug Dev Ind Pharm ; 46(11): 1809-1818, 2020 Nov.

Article em En | MEDLINE | ID: mdl-32903067

Assuntos

Trióxido de Arsênio; Implantes de Medicamento; Animais; Disponibilidade Biológica; Preparações de Ação Retardada; Ratos; Solubilidade

Palavras-chave

Arsenic trioxide; compliance; oral bioavailability; pellets; sustained-release; toxicity

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Implantes de Medicamento / Trióxido de Arsênio Limite: Animals Idioma: En Revista: Drug Dev Ind Pharm Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google